Skip to content

Johnson & Johnson

JNJ· NYSECore metricsCIK 200406

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · +1.15%
Market cap
$682.62B
2.41B shares
Filings
1,064
$25.40B
Q3 2026+6.0% FY25 yoy
$210.00M
Q3 2026+90.6% FY25 yoy
$5.83B
Q1 2015+31.6% FY14 yoy
$15.12B
Q3 2026derived−0.7% FY25 yoy
$0.09
Q3 2026+90.5% FY25 yoy
$16.91B
Q3 2026−18.2% FY25 yoy
$682.62B
42.4×
6.9×
8.4×
3.02%
—

Twelve months to Sep 27, 2026 · derived

Price

$283.56+46.26%+$89.69past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$94.19BFY 2025
$94.19B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-28$94,193,000,000reported
FY 20242024-12-29$88,821,000,000reported
FY 20232023-12-31$85,159,000,000reported
FY 20222023-01-01$79,990,000,000 revisedreported
FY 20212022-01-02$78,740,000,000 revisedreported
FY 20202021-01-03$82,584,000,000reported
FY 20192019-12-29$82,059,000,000reported
FY 20182018-12-30$81,581,000,000reported
FY 20172017-12-31$76,450,000,000reported
FY 20162017-01-01$71,890,000,000reported
FY 20152016-01-03$70,074,000,000reported
FY 20142014-12-28$74,331,000,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$5.95B$5.95B$5.142.41B sh+0.1%30.2%
FY2024—$2.43B$2.43B$4.912.41B sh−0.0%12.3%
FY2023—$5.05B$5.05B$4.702.41B sh−7.5%27.7%
FY2022—$6.04B$6.04B$4.452.60B sh−1.0%35.1%
FY2021—$3.46B$3.46B$4.192.63B sh+0.0%17.5%

Segments

Revenue by Segments, FY2018 to FY2025FY2018Consumer Health · FY2018 · $13.85BMedical Devices · FY2018 · $26.99BPharmaceutical · FY2018 · $40.73BFY2019Consumer Health · FY2019 · $13.90BMedical Devices · FY2019 · $25.96BPharmaceutical · FY2019 · $42.20BFY2020MedTech · FY2020 · $22.96BConsumer Health · FY2020 · $14.45BMedical Devices · FY2020 · $22.96BPharmaceutical · FY2020 · $45.18BFY2021MedTech · FY2021 · $27.06BConsumer Health · FY2021 · $15.04BMedical Devices · FY2021 · $27.06BPharmaceutical · FY2021 · $51.68BFY2022MedTech · FY2022 · $27.43BConsumer Health · FY2022 · $14.95BPharmaceutical · FY2022 · $52.56BFY2023Innovative Medicine · FY2023 · $54.76BMedTech · FY2023 · $30.40BFY2024Innovative Medicine · FY2024 · $56.96BMedTech · FY2024 · $31.86BFY2025Innovative Medicine · FY2025 · $60.40BMedTech · FY2025 · $33.79B
LineFY2025ShareChange
Innovative Medicine$60.40B64%+6.0%
MedTech$33.79B36%+6.1%
Consumer Health———
Medical Devices———
Pharmaceutical———
Total$94.19B

From the 10-K filed Feb 11, 2026JNJ

Pharmaceutical preparations

Johnson & Johnson is the largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Johnson & Johnson · CIK 200406 · Engraved from SEC EDGAR